Invesco Biotechnology & Genome ETF
PBE
PBE
97 hedge funds and large institutions have $73.9M invested in Invesco Biotechnology & Genome ETF in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 31 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
48% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 31
Holders
97
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.8M | |
| 2 | +$562K | |
| 3 | +$510K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$471K |
| 5 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
+$315K |
Top Sellers
| 1 | -$3.04M | |
| 2 | -$562K | |
| 3 | -$334K | |
| 4 |
SIA
SkyView Investment Advisors
Shrewsbury,
New Jersey
|
-$213K |
| 5 |
PWM
PRW Wealth Management
Quincy,
Massachusetts
|
-$208K |